Health·2,839 stories
Four years after the European Commission unveiled what was hailed as its largest-ever ban on toxic chemicals, a new report finds it has failed to begin regulating seven of 22 hazardous substance group
After surviving three cash crises, CAR‑T pioneer Kelonia Therapeutics secured a $3.25 billion buyout by Eli Lilly, underscoring how high‑risk biotech turnarounds can translate into massive exits. At t
Amid mounting legal scrutiny and a foreign‑policy spotlight, Trump touts a domestic win: the final drug‑pricing pact with Regeneron, capping a series of 17 White House‑initiated deals. The agreement c
A mouse study led by researchers at the International Centre for Genetic Engineering and Biotechnology shows that the heart’s relentless beating creates mechanical stress that suppresses tumor growth,
Facing mounting legal scrutiny, President Trump shifted his agenda to drug policy, signing a $50 million executive order to fast‑track FDA approval of psychedelics and urging the DEA to lower marijuan
Mouse experiments show respiratory syncytial virus (RSV) triggers an immune response that reduces breast cancer cells seeding in the lungs by 65-70%, with researchers identifying type I interferons an
Garijo steps in as Sanofi’s new CEO this month, inheriting a pipeline dominated by immunology after a series of lackluster trial outcomes. The biotech landscape also sees a gene‑therapy for deafness m
A new analysis of 617,186 participants from the UK Biobank and All of Us shows that Epstein‑Barr virus concentrates in B‑cells, hijacking them and triggering genes linked to multiple sclerosis. The wo
Health officials are flagging the growing financial ties between drugmakers and telehealth platforms, warning they may breach anti‑kickback rules and push costly prescriptions, while the FDA has just
Northwestern researchers have followed a cohort of 80‑year‑olds dubbed SuperAgers, whose memory rivals that of people 30 years younger. Brain scans reveal a distinct neurobiological profile that resis
Scientists at McGill University and the Douglas Institute applied single‑cell genomics to post‑mortem brain tissue, revealing that excitatory neurons and a microglia subtype are the cellular drivers o
Sprout Pharmaceuticals is pairing a $10 telehealth visit with a coupon code to funnel more patients toward its low‑libido drug Addyi, now approved for all women under 65. The arrangement, run through
A blinded, sham‑controlled trial presented at Digestive Disease Week shows that duodenal mucosal resurfacing, an endoscopic heat‑ablation of the duodenum, dramatically reduces weight regain after pati
RMIT University scientists have created a flexible acrylic plastic film covered in nanopillars that physically tears viruses apart on contact, disabling about 94% of human parainfluenza virus particle
UC Irvine researchers showed that injecting older mice with a targeted polyunsaturated fatty acid reversed age‑related retinal decline, restoring visual function and cellular aging markers, offering a
A surge in radioligand therapy is driving a global scramble for scarce radioactive isotopes. Researchers at the UK’s National Nuclear Laboratory are turning nuclear waste into usable lead, while firms
Campaigners for lobular breast cancer—a stealthy form affecting 15 % of UK patients—are demanding a £20 m research programme after staging vigils outside Downing Street. The Lobular Moon Shot Project,
NYU Langone researchers found that the neutrophil-to-lymphocyte ratio, a standard measure from routine blood counts, is linked to a higher risk of developing Alzheimer's and other dementias years befo
NASA’s Artemis II success speeds its lunar‑base agenda, yet spaceflight‑induced immune changes and evolving microbes threaten crew health on the Moon and Mars. The piece urges NASA to embed immunology
Journalist Thomas Goetz uses his new “Drug Story” podcast to turn each of the over 3,000 medicines on pharmacy shelves into a narrative about health, society, and economics. By dissecting drugs like A
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.